Scott Neuville Takes Over as CEO at Chesson Labs

Durham, N.C. — Scott Neuville is the new president and chief executive officer at biotech startup Chesson Labs.

The decision to hire Neuville follows the departure of Chesson Labs David Terry, who was CEO and a co-founder of the firm. He left the company in December, a company spokesperson told WRAL Local Tech Wire.

Neuville recently left Qualyst, a developer of drug testing technology, as part of a management shakeup at that firm.

A Chesson spokesperson confirmed Neuville’s hiring.

Chesson was formed in September 2006. It is in the process of developing a liquid skin bandage as well as other products focused on dermatitis and nail fungus. The firm licensed for medical products a patented polymer developed by RMI Polymers.

Neuville is the former chairman of the board and CEO of iBiomatics, a SAS company. iBiomatics was the first healthcare technology spin-off of SAS Institute, the worlds largest privately held software company. Neuville had led Qualyst since 2002.

Chesson has recently been in the process of raising $5 million in venture capital.

Terry formed the company along with Jerry Chesson, who discovered the technology on which Chesson Labs is based.